McNeil Chooses Litigation To Challenge Glaxo’s OTC Flonase Ad Claims
This article was originally published in The Tan Sheet
Executive Summary
The J&J consumer products subsidiary, which markets the Zyrtec and Benadryl OTC allergy lines, foregoes industry self-regulation channels to hasten a decision in its challenge of Glaxo’s recently launched Flonase Allergy Relief.